Pediapred

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pediapred

Quick Facts

Property Description
Active ingredient Prednisolone
Form Oral Solution (Liquid)
Pharmacological class Glucocorticoid; Adrenocortical Steroid
General Purpose Systemic anti-inflammatory and immunosuppressant
Origin Synthetic

The Identity and Class of Pediapred

Pediapred is a prescription-only medication whose active substance is the corticosteroid prednisolone, which scientifically belongs to the class of glucocorticoids and is a type of adrenocortical steroid. Prednisolone is a potent synthetic agent that mimics the regulatory functions of natural hormones produced by the adrenal glands. The clinical utility of prednisolone is found in its capacity to regulate numerous physiological pathways. This potent classification underpins the drug's widespread influence on the body's major systems when systemic steroid therapy is necessary.

Composition and Formulation as an Oral Solution

The active compound in this medication is prednisolone, delivered as the readily soluble salt, prednisolone sodium phosphate. Pediapred is a single-agent product formulated specifically as an Oral Solution—a clear, water-based, liquid preparation—making the oral route of administration simple. This liquid dosage form is a key differentiator, making the medication especially suitable for pediatric patients or others who encounter difficulty swallowing solid tablets. This formulation ensures that the active drug is quickly available for systemic effect following ingestion.

General Purpose: Managing Inflammation and Immunity

The general purpose of this corticosteroid is to serve as a potent anti-inflammatory agent and an immunosuppressant, systemically controlling severe physiological responses. Glucocorticoids like prednisolone function by regulating gene transcription to broadly control inflammation. This mechanism allows the medicine to aggressively control severe, systemic states, such as managing a significant inflammatory flare-up. This fundamental dual action provides robust relief by modulating the body's overactive defense and repair mechanisms.

Regulatory References

  1. confirms prednisolone is a potent synthetic agent
  2. confirms the core function of glucocorticoids like prednisolone

What side effects are possible with Pediapred?

Possible Side Effects and Safety Information

The safety profile of prednisolone, the active ingredient in Pediapred, is broadly defined across multiple body systems, reflecting its potent systemic glucocorticoid activity, as documented in official government regulatory texts (e.g., FDA, SmPC).


Regulatory Classification of Adverse Reactions

The FDA and other regulatory agencies classify certain effects by frequency. Common adverse reactions include fluid retention, elevation in blood pressure (hypertension), increased appetite, weight gain, and alteration in glucose tolerance. Many other effects are officially categorized as Not Known frequency, relying on post-marketing reports.


Adverse Effects by System-Organ Class

Adverse effects are grouped by system, including Endocrine Disorders (e.g., HPA axis suppression), Metabolic Disorders (e.g., potassium loss), Psychiatric Disorders (e.g., mood swings, severe depression), Musculoskeletal Disorders (e.g., osteoporosis, muscle weakness), and Gastrointestinal Disorders.


Serious Adverse Reactions and Safety Constraints

Official labels document serious adverse reactions such as peptic ulceration with possible hemorrhage or perforation, severe psychosis, and increased intracranial pressure (pseudotumor cerebri). The drug is generally contraindicated in individuals with systemic fungal infections. Furthermore, live vaccines must be avoided during immunosuppressive dosing.


Population and Duration-Related Safety Notes

Safety characteristics are linked to duration. Prolonged use is officially associated with the risk of developing osteoporosis and cataracts. For pediatric patients, long-term use may cause suppression of growth, and infants born to mothers who received the drug should be monitored for hypoadrenalism.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory information provides guidance for both acute overdose and the effects of chronic, high-dose use of Pediapred (prednisolone).

An acute overdose of prednisolone is not typically expected to produce life-threatening symptoms.


Key Overdose Considerations

Condition/Risk Official Statement Seeking Help
Acute Overdose Not expected to produce life threatening symptoms. Call Poison Help line (1-800-222-1222).
Chronic High Dose Long term use of high steroid doses can lead to symptoms such as thinning skin, easy bruising, changes in the shape or location of body fat (e.g., in the face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex. Consult a healthcare professional.
Severe Emergency If the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Immediately call emergency services at 911.

When Immediate Medical Attention is Required

Immediate medical attention is required for serious symptoms of overdose, such as passing out or trouble breathing. In these severe cases, or if the individual has collapsed or experienced a seizure, emergency services should be contacted immediately by calling 911. Otherwise, for suspected overdose or accidental exposure, individuals should contact a certified poison control center right away.

Therapeutic Uses of Pediapred

What Pediapred Treats: Main Uses and Benefits

The active compound is commonly used in areas where short-term symptom management is appropriate. This oral solution is commonly used across conditions presenting with acute episodes and is relevant in clinical settings that involve acute or unstable symptom patterns, and may be relevant for pediatric patients where the liquid formulation assists with administration.

Pediapred helps address conditions characterized by periods of heightened symptoms, including acute exacerbations of rheumatoid arthritis and lupus, severe allergic reactions, asthma attacks, certain inflammatory bowel diseases (like ulcerative colitis), and edematous states associated with nephrotic syndrome. It is used to manage systemic symptoms that create noticeable interference with daily stability.

“The medication is applied in addressing symptom clusters that may become intense or disruptive during acute episodes.”

This approach provides support that helps ease the overall burden of severe inflammation, contributing to easing the overall symptom load during periods of heightened symptoms. The medication is considered relevant for providing symptomatic relief, which may assist patients in coping more steadily with these challenging manifestations.


Quick Fact: Relief for Inflammation

Property Description
Symptoms the Medication Helps Manage Widespread swelling, tenderness, restricted function
Patient-Oriented Benefits Supportive relief during episodes associated with acute symptomatic changes
Common Scenarios Asthma attacks, autoimmune disease exacerbations, severe allergies

Eligibility and Restrictions for Use

This section summarizes the official eligibility and non-eligibility rules for Pediapred (prednisolone sodium phosphate oral solution) as defined in government regulatory labeling.

Contraindications (Must Not Use)

Category Regulatory Status
Infection Status Contraindicated in patients with untreated systemic fungal infections or other certain active infections (e.g., chickenpox, measles).
Allergy Contraindicated in patients with known hypersensitivity to prednisolone or any components of the formulation.

Conditional Use and Restrictions

Category Eligibility Rule
Age Groups Approved for use in adult and pediatric populations. Children on long-term therapy must be monitored for slowed growth. Older adults may require caution due to age-related organ issues.
Pregnancy/Lactation Pregnancy use is restricted due to potential for fetal harm (e.g., adrenal suppression). Lactation requires weighing benefits against risks, as the medicine passes into breast milk.
Comorbidities Caution is required for patients with conditions like cirrhosis, hypothyroidism (enhanced drug effect), hypertension, renal insufficiency, certain gastrointestinal disorders (e.g., active peptic ulcer), and ocular herpes simplex.
Vaccination Patients receiving immunosuppressive doses must not be administered live or live attenuated vaccines due to the risk of neurological complications and reduced immune response.

This framework specifies that eligibility is conditional, based not only on age but also on the presence of certain concurrent diseases, infections, or physiological states.

What should I know about interactions with other medicines?

Pediapred (prednisolone sodium phosphate) may interact with several other medicinal products, requiring dose adjustments or careful monitoring.

Drug Interactions Overview

Interacting Product Category Potential Effect & Clinical Note
CYP 3A4 Inducers (e.g., Rifampin, Phenytoin) May decrease Pediapred levels, potentially reducing its effect.
CYP 3A4 Inhibitors (e.g., Ketoconazole, Hormonal Contraceptives) May increase Pediapred levels, potentially increasing the risk of side effects.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Increased risk of serious gastrointestinal side effects (e.g., GI ulceration).
Anticoagulants (e.g., Warfarin) May alter the anticoagulant effect, requiring close monitoring of coagulation indices.
Antidiabetic Agents (including insulin) May increase blood glucose concentrations, necessitating adjustments in the antidiabetic regimen.
Diuretics (e.g., Thiazides, Loop Diuretics) Increased risk of hypokalemia (low potassium levels).
Cyclosporine Concurrent use can lead to increased activity of both drugs, and convulsions have been reported.

Vaccination: Patients should not receive live or live-attenuated vaccines while on immunosuppressive doses of Pediapred, as the vaccine may not be fully effective due to reduced immune response. Exposure to viral infections like varicella (chickenpox) or measles in non-immune patients requires immediate medical attention for appropriate prophylaxis.

Mechanism of Action

Pediapred contains prednisolone sodium phosphate, which hydrolyzes to the active synthetic glucocorticoid, prednisolone. Prednisolone is an agonist at intracellular glucocorticoid receptors (GCRs), located primarily within the cytoplasm of target cells. The lipophilic prednisolone molecule diffuses across the cell membrane and binds to the GCR. This binding event facilitates the dissociation of chaperone proteins, permitting the active glucocorticoid-receptor complex to translocate into the cell nucleus.

Within the nucleus, the complex functions as a transcription factor, binding to specific DNA sequences known as glucocorticoid response elements (GREs). This interaction modulates gene expression, resulting in both transactivation (increased synthesis) of anti-inflammatory proteins, such as lipocortin-1, and transrepression (inhibition) of pro-inflammatory genes. Transrepression involves direct protein-protein interaction with other transcription factors, including Nuclear Factor-Kappa B (NF-κB) and Activator Protein 1 (AP-1), thereby inhibiting the transcription of genes encoding inflammatory mediators like cytokines (e.g., IL-1, IL-6, TNF-α), chemokines, and cyclooxygenase-2 (COX-2). The system-level physiological consequence of this dual genomic and non-genomic action is a broad suppression of immune cell function and inhibition of multiple inflammatory cascades, encompassing reduced edema, decreased capillary dilation, and inhibited leukocyte migration at targeted tissues. Prednisolone also exhibits weak mineralocorticoid activity, promoting sodium retention and potassium excretion.

Dosage and Administration Information

Pediapred, which is formulated as a liquid, is administered exclusively by the oral route. The fundamental principle governing its use is that the dosage must be highly individualized based on the specific condition being treated and the patient's overall response. For adults, initial daily dosage ranges broadly, typically between 5 mg and 60 mg of prednisolone base. Once the desired control is achieved, the dosage is reduced by titration to the lowest possible maintenance level that sustains an adequate clinical response.

The administration schedule may consist of a single daily dose or be divided into multiple doses. If administered once daily, the dose is conventionally taken in the morning to coincide with the body’s natural rhythm of corticosteroid production. To minimize the potential for gastrointestinal irritation, the solution is ingested with food or milk. Accurate measurement is a procedural requirement; the liquid must be dispensed using a calibrated measuring device.

Usage patterns often involve short-term administration for acute episodes. For high-dose or prolonged treatment courses, the dose must be gradually tapered when discontinuing therapy, and abrupt cessation is strictly not permitted. Pediatric dosages are not fixed and are commonly calculated based on body surface area or body weight (e.g., 0.14 to 2 mg/kg/day), and are frequently given in divided doses.

Recent Clinical Evidence

Recent Research Evidence Overview

Pediapred is an oral solution containing prednisolone sodium phosphate, a corticosteroid used to manage various inflammatory and immune-mediated conditions. The compound's efficacy and safety profile are primarily established through decades of research on systemic corticosteroids.

Clinical Efficacy and Outcomes

Research explores whether the compound influences specific inflammatory pathways, particularly targeting the activity of certain pro-inflammatory factors. Studies have investigated changes in symptoms across various conditions for which the product is indicated, including:

  • Acute Asthma Exacerbations: A randomized, controlled trial involving young children (6 to 35 months) with viral respiratory distress found that a short course of oral prednisolone was evaluated for its effect on reducing the duration of respiratory symptoms and the length of hospital stay when compared to placebo.
  • Nephrotic Syndrome: Clinical trials have examined the optimal duration of initial prednisolone therapy in children with new-onset idiopathic nephrotic syndrome. Research explored the course of disease following initial therapy lasting three months versus six months, particularly in children under four years old.
  • Rheumatic and Allergic Conditions: The compound is evaluated in numerous inflammatory and allergic states, based on its established systemic action in reducing inflammation and suppressing immune response.

Safety and Tolerability Findings

Study findings do not constitute medical advice. A sub-analysis of one trial looked at participants with severe kidney issues, a population where clearance of the compound may be slowed. The compound was evaluated in most adult and pediatric populations.

Commonly reported events in trials for acute use include mild gastrointestinal distress and temporary fatigue. The well-established adverse event profile for glucocorticoids, including potential for growth suppression with prolonged use, necessitates careful medical monitoring.

Frequently Asked Questions (FAQ)

Common questions about Pediapred (FAQ)


Q: What types of severe allergies is Pediapred typically used for?

Official regulatory documents indicate that prednisolone, the active ingredient in Pediapred, is used for severe allergic conditions that have not adequately responded to standard treatments. Specific examples listed on product labels include severe seasonal or perennial allergic rhinitis, drug hypersensitivity reactions, serum sickness, and atopic dermatitis.

Q: How quickly should a patient expect to see the effects of Pediapred treatment?

The onset of action for a glucocorticoid like prednisolone can be quite fast. While initial effects begin quickly, the full anti-inflammatory and immunosuppressive actions, which involve changes at the cellular and genetic level, typically develop over a period ranging from a few hours to a couple of days.

Q: Can Pediapred cause problems with sleep or insomnia?

Yes, official product information lists insomnia, or difficulty sleeping, as a potential neurological adverse reaction associated with prednisolone. Due to this potential effect, the medicine is often recommended to be taken in the morning to align with the body’s natural hormone cycle.

Q: Do the common side effects like increased appetite go away when the medicine is stopped?

Common side effects associated with glucocorticoids, such as increased appetite, fluid retention, and elevation in blood sugar, are often temporary. Resolution of these effects may be expected after the medicine is discontinued or the dose is reduced. However, recovery time for certain long-term effects, like bone loss, is variable.

Q: Can Pediapred affect the results of certain laboratory blood tests?

Official documentation states that prednisolone can alter the results of several laboratory tests. It may cause an increase in blood sugar and sodium levels, a decrease in potassium and calcium levels, and changes in certain immune cell counts.

Q: What are the signs of a serious allergic reaction to Pediapred?

While the medicine is contraindicated for individuals with known hypersensitivity to the drug, regulatory labels describe the signs of a serious allergic reaction that may be noted in the official documentation. These signs can include the appearance of rash, hives, or swelling of the face, tongue, or throat.

Q: Does Pediapred have a specific flavor or taste that makes it difficult to take?

The official product labeling confirms that Pediapred (prednisolone sodium phosphate oral solution) is generally formulated as a raspberry-flavored liquid solution. This formulation is often used to make the oral route of administration easier, particularly for children.

Q: How long after stopping Pediapred can its effects still be present in the body?

The drug's active substance, prednisolone, is eliminated from the plasma with a half-life of 2 to 4 hours. However, the functional effects can last much longer. Long-term use can suppress the body’s natural production of steroids (HPA axis), and regulatory instructions indicate that monitoring may be required for up to a year after chronic use is stopped.

Q: Are Pediapred and prednisone the same type of medicine?

Pediapred contains prednisolone, which is very closely related to prednisone. Prednisolone is the active substance that works in the body. Prednisone is considered a prodrug, meaning the body (specifically the liver) must first convert prednisone into prednisolone for it to be active.

Q: What is the difference between Pediapred liquid and prednisolone tablets?

Pediapred is formulated as an oral liquid solution, which is especially useful for children or individuals who have difficulty swallowing solid tablets. Official regulatory data suggests that the liquid solution may result in a faster onset of action and achieve a higher peak level of the drug in the blood compared to tablet forms.

Q: Can Pediapred cause headaches or dizziness?

Yes, official adverse reaction reports associated with prednisolone use list headache as a potential neurological effect. Dizziness is not explicitly mentioned, but other central nervous system effects are documented in product labels.

Q: Are there any general dietary restrictions while taking Pediapred?

According to regulatory warnings, patients taking corticosteroids may need to follow dietary restrictions. Because the drug can cause salt and water retention, healthcare providers may recommend dietary salt restriction and sometimes advise potassium supplementation to balance mineral levels.

Q: What should be done about a missed single dose of Pediapred?

Official patient information generally describes the procedure for a missed dose. Guidance indicates that if a dose is missed, it may be taken as soon as the patient remembers. If it is almost time for the next scheduled dose, the missed dose is typically skipped, and the instructions advise against taking a double dose to compensate.

Q: Can Pediapred interact with herbal supplements or natural products?

While regulatory interaction tables focus primarily on prescription and over-the-counter medicines, patients are broadly advised to inform their healthcare provider of all products they are taking. This includes all supplements and herbal products, as these can potentially influence the drug’s effect and may require a dosage adjustment.

Q: Is it true that Pediapred can mask the signs of an infection?

Yes, regulatory warnings confirm that systemic corticosteroids like prednisolone may mask some of the typical signs of infection. Because the drug suppresses the immune response, there may be decreased resistance, and the body may be unable to quickly localize or contain an infection when the medicine is used.

Q: Why is Pediapred sometimes prescribed for skin conditions like contact dermatitis?

Pediapred is indicated for treating various skin (dermatologic) diseases due to its strong anti-inflammatory effects. Official indications include conditions such as contact dermatitis and severe erythema multiforme, which are often characterized by significant inflammation.

Q: How often does a patient need monitoring or blood tests while on long-term Pediapred therapy?

Official information emphasizes that patients on long-term corticosteroid therapy require regular monitoring by their healthcare provider. Monitoring may include checking for HPA axis suppression, bone density, and blood glucose concentrations.

Q: What is the difference between a corticosteroid and an anabolic steroid?

Corticosteroids, such as Pediapred, are primarily used to reduce inflammation and suppress the immune system. Anabolic steroids are chemically distinct and are used to promote muscle growth, which is why they are sometimes misused in sports.

Q: Can Pediapred cause acne or thinning of the skin?

Yes, official documentation lists several adverse reactions related to the skin (dermatologic). These include the onset of acne and the development of thin fragile skin (skin thinning) with prolonged use.

Q: Why is it important to tell a dentist or surgeon about taking Pediapred before a procedure?

Regulatory warnings advise that patients on corticosteroids who may be subjected to unusual physical stress, such as major trauma or surgical procedures, should notify all healthcare providers. This is because official guidance indicates that these patients may require an increased dosage of corticosteroids.

Q: Is Pediapred used to treat conditions other than just asthma and allergies?

Yes, the medication is officially indicated for numerous conditions beyond asthma and allergies. Official drug documentation states that it is used to manage a wide range of inflammatory and immune-mediated conditions across various body systems. These include certain rheumatic disorders and blood disorders, in addition to conditions like nephrotic syndrome.

Q: What does the term "idiopathic" mean in relation to some conditions Pediapred treats?

The term 'idiopathic' appears in the official drug indications for conditions like 'idiopathic nephrotic syndrome' and 'idiopathic thrombocytopenic purpura.' In medical language, the use of this term simply means that the cause of the specific disease is unknown.

Q: What is adrenal suppression and how does Pediapred relate to it?

Adrenal suppression is a serious effect where the body's adrenal glands temporarily reduce or stop producing natural glucocorticoids. This occurs because Pediapred provides the body with external steroid hormones. Due to this effect, the regulatory guidance states the dose must be gradually reduced (tapered) after long-term use, and abrupt cessation is contraindicated.

Q: Are mood changes like irritability or hyperactivity common side effects in children?

Official safety information lists psychiatric disturbances that include general mood swings and severe depression. Although specific terms like 'irritability' and 'hyperactivity' are not always listed in regulatory language, changes in mood and behavior fall within the documented spectrum of central nervous system effects for glucocorticoids.

Q: Can Pediapred increase the risk of getting a cold or flu?

Because Pediapred acts as an immunosuppressant, official warnings indicate that it can decrease the body's resistance to infection. While severe viral infections like chickenpox and measles are the focus of official warnings, this general immunosuppression means there is an increased potential vulnerability to all types of infections, including common colds and influenza.

Q: What is the risk of developing cataracts or glaucoma from Pediapred?

Official safety notes confirm that prolonged use of Pediapred is associated with the risk of developing eye issues, including cataracts. Furthermore, systemic corticosteroids are also broadly associated with an increased risk of developing glaucoma (increased pressure in the eye).

Q: Is it normal to feel tired or weak after stopping Pediapred?

Official information indicates that temporary fatigue is sometimes reported during acute clinical trials. Additionally, when stopping the drug, the body may experience temporary weakness or fatigue as the natural production of cortisol (HPA axis) gradually recovers from suppression. This is why a tapered reduction is necessary.

Q: Does taking Pediapred for a short time still require a gradual reduction in dose?

Official procedural requirements mandate that the dose must be gradually tapered when discontinuing therapy following 'high-dose or prolonged treatment courses.' While short-term, acute use may not always require a full taper, the guidance strongly advises against abrupt cessation and notes that a gradual reduction is necessary to help lower the risk of withdrawal effects.

Q: Is there a maximum recommended duration for taking Pediapred?

Official documents do not define a specific, fixed maximum number of days or weeks for all patients, as the duration is highly individualized based on the condition being treated. Instead, the medication is often administered for 'short-term' acute episodes. However, warnings consistently state that prolonged use is officially associated with known serious risks, such as growth suppression and bone loss.

How should Pediapred be stored and disposed of?

How to Store and Dispose of Pediapred?

The official requirements for the storage and disposal of Pediapred (prednisolone sodium phosphate oral solution) are designed to maintain the drug's stability and ensure safety.


Storage Requirements

Condition Requirement (Based on Regulatory Labeling)
Temperature Store at Controlled Room Temperature (20°C to 25°C / 68^circF to 77^circF).
Prohibited Handling Do not refrigerate. Do not freeze.
Protection Mandatory to Protect from light.
Container Keep the container tightly closed and in the original container.
Safety Must be kept out of the reach of children.

Disposal Instructions

Any unused or expired Pediapred oral solution must be disposed of in accordance with local, state, and federal regulations for discarding pharmaceutical products. This protocol prevents inappropriate use and ensures environmental safety.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pediapred found in:

A-Z Index: